Ellipse Technologies Enhances Executive Management Team
September 21 2015 - 8:46PM
Ellipse Technologies, Inc., a global medical device company,
announced today the appointments of Jeff Rydin as Chief Sales
Officer and Bob Krist as Chief Financial Officer.
Jeff Rydin joins Ellipse after most recently serving as
President of Global Sales at NuVasive, Inc. (NASDAQ:NUVA), a
medical device company focused on developing products for minimally
invasive surgical treatments for the spine. Prior to NuVasive, Mr.
Rydin was Area Vice President at DePuy Spine, Inc. where he managed
a $100 million division and established a sales team in the
Southeastern U.S. over his three-year tenure. Mr. Rydin also served
in various executive and leadership sales roles at Orquest
(acquired by Johnson & Johnson), Symphonix, General Surgical
Innovations (acquired by Tyco International), Baxter Healthcare,
and Xerox.
Bob Krist most recently served as Chief Financial Officer at
Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of
innovative minimally invasive treatments for aortic disorders. At
Endologix, Mr. Krist was responsible for building the company's
financial infrastructure, overseeing several equity capital raises.
Prior to Endologix, Mr. Krist served as Chief Financial Officer of
CardioNet, Inc., a privately held marketer of mobile cardiac
outpatient telemetry tools and services, where he also played a key
role in developing the company's business model and overseeing
several equity and debt capital raises. Mr. Krist has held several
other executive management positions at public and private
healthcare companies.
Ed Roschak, President and Chief Executive Officer of Ellipse
commented, "the addition of these two seasoned executives
significantly enhances our leadership team. As NuVasive's President
of Global Sales, Jeff helped grow revenues from $38 million to over
$600 million. Bob offers deep public company CFO and SEC reporting
experience. While at Endologix, the company experienced rapid
product adoption while he oversaw several public equity financings.
We are very fortunate to have these two highly experienced, proven
executives join the Ellipse team, and we look forward to the
contributions they will both make as we drive adoption of our
adjustable implant technology."
About Ellipse Technologies
Ellipse Technologies, Inc. is a privately held medical
technology company located in Aliso Viejo, California. The Company
is focused on revolutionizing orthopedic surgery by developing and
marketing a new generation of magnetically adjustable implant
systems based on the MAGnetic External Control, or MAGEC®
technology platform. The Company's novel and proprietary implants
are adjustable at the time of implantation and non-invasively over
the course of treatment to accommodate the changing clinical needs
of patients as they heal, grow or age. This technology provides
significant improvements in patient clinical outcomes and quality
of life while generating significant cost savings to the healthcare
system. For more information, visit www.ellipse-tech.com.
CONTACT: Investor Contacts:
Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
nlaudico@theruthgroup.com
zkubow@theruthgroup.com
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Apr 2023 to Apr 2024